ProQR Announces Results for the Third Quarter of 2016
Nov 14, 2016 12:01 pm UTC| Business
LEIDEN, the Netherlands, Nov. 14, 2016 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases...
Nov 14, 2016 12:01 pm UTC| Business
Enhanced Tumor Rejection in Colorectal Cancer Mouse Model Combined Synergistically with PD1 and PD-L1 Checkpoint Inhibitors DURHAM, N.C., Nov. 14, 2016 -- Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the...
Nov 14, 2016 12:01 pm UTC| Business
Enhanced Tumor Rejection in Colorectal Cancer Mouse Model Combined Synergistically with PD1 and PD-L1 Checkpoint Inhibitors DURHAM, N.C., Nov. 14, 2016 -- Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the...
Nov 14, 2016 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Nov. 14, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced an interim data analysis showing that its INO-3112 cancer immunotherapy product generated antigen-specific CD8+ killer T...
Nov 14, 2016 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Nov. 14, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced an interim data analysis showing that its INO-3112 cancer immunotherapy product generated antigen-specific CD8+ killer T...
Nov 14, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today reported encouraging preclinical efficacy for the treatment of neuropathic pain and visceral pain with their novel...
Nov 14, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today reported encouraging preclinical efficacy for the treatment of neuropathic pain and visceral pain with their novel...